Immunochromatographic (IC) test for norovirus detection is a rapid and simple detection method. This study evaluated the sensitivity and specificity of a recent version of R-Biopharm RIDAV R QUICK Norovirus IC assay for norovirus detection in fecal specimens from children hospitalized with acute gastroenteritis. Fecal specimens were tested by IC kit in comparison with gold standard reverse transcription polymerase chain reaction (RT-PCR) and real-time RT-PCR. The IC kit showed high sensitivity and specificity comparable with PCR-based methods. None of false positive and false negative was found and the assay did not cross-react with other gastroenteritis viruses. The IC assay could detect genogroup I.5 (GI.5) and a wide range of genotypes in the GII noroviruses including GII.3, GII.4, GII.6, GII.7, GII.14, GII.15, GII.21, and also newly emerging GII.17 norovirus. In conclusion, this norovirus IC kit could be an alternative choice for rapid screening or a quick diagnostic tool for norovirus detection in fecal specimens of acute gastroenteritis patients.
time RT-PCR and immunochromatographic (IC) assay [2, 5, 6] . The PCR-based method is a gold standard method for the detection of norovirus, but this method generally requires expensive/special laboratory equipment, well-trained personnel and is time-consuming. Thus, it could not be widely applied for small hospitals, particularly in developing countries. In contrast, the IC assay, which is a quick, easy and less expensive method, could be a choice for rapid screening tests. Nowadays, several commercial IC kits for norovirus detection are commercially available. Among them, the RIDA V R QUICK Norovirus IC assay has been evaluated in several studies [7] [8] [9] [10] [11] [12] with good sensitivity (52-87%) and high specificity (98-100%) compared with gold standard PCR-based methods. Because the updated version of this IC kit (N1402) has been recently introduced, the use of this kit with clinical specimens from Thai children with acute diarrhea has not been fully applied. This study aimed to evaluate the efficacy of the updated RIDA V R QUICK Norovirus IC assay comparing with RT-PCR and real-time RT-PCR methods.
M A T E R I A L S A N D M E T H O D S
Fecal specimens and study design Fecal specimens were collected from children hospitalized with acute gastroenteritis in three hospitals in Chiang Mai, Thailand during 2014 to 2016. From 1093 fecal specimens, 40 representative specimens of known norovirus-positive (n ¼ 32) or -negative (n ¼ 8) specimens, as tested by RT-PCR, were included in this study. The norovirus-positive samples were composed of a wide variety of genotypes of norovirus GI and GII and used for evaluation of the sensitivity of the methods used in this study. The norovirus-negative samples were used for evaluation of the specificity and cross-reactivity of the tests.
Moreover, all specimens were tested for the presence of gastroenteritis viruses including group A rotavirus, adenovirus, astrovirus, sapovirus, saffold virus and enterovirus by using PCR or RT-PCR as described previously [13] [14] [15] [16] . The specimens were kept at À20 C until used. The study was conducted with the approval of the ethical committee for human rights related to human experimentation, Faculty of Medicine, Chiang Mai University (MIC-2557-02710).
The R-biopharm RIDA V R QUICK norovirus (N1402) IC assay All fecal specimens were tested by the RIDA V R QUICK Norovirus Version N1402 (R-Biopharm AG, Darmstadt, Germany) qualitative IC norovirus detection kit according to the manufacturer's instruction. Briefly, fecal specimen was prepared in sample dilution buffer and homogenized by thoroughly mixing. Then sample was allowed to stand for 5 min to yield a particle-free supernatant. A total of 150 ml of the supernatant was added into the sample well of the test cassette. The results could be read within 15 min.
Extraction of viral RNA and RT Viral RNA was extracted from 200 ml of fecal suspension (10%, w/v) using Geneaid Viral Nucleic Acid Extraction Kit II (Geneaid Biotech Ltd., Taipei, Taiwan) according to the manufacturer's protocol. The extracted viral RNA was reverse transcribed to generate complementary DNA using random hexamer primers (Takara Bio Inc., Shiga, Japan) and RevertAid TM reverse transcriptase (Thermo Fisher Scientific, Waltham, MA) according to the manufacturer's instruction.
Detection of norovirus by PCR and semi-nested PCR For GI norovirus detection, G1SKF and G1SKR primers [17] (Table 1) were used for amplification of partial VP1 gene (330 bp) using GoTaq V R Green Master Mix (Promega, Madison, WI, USA). For the detection of GII norovirus, semi-nested PCR was performed with COG2F, G2SKF and G2SKR primers for amplification of 387 bp and 340 bp of first-round and second-round PCR products, respectively [17, 18] . The PCR products were purified using a Gel/PCR DNA Fragment Extraction Kit (Geneaid) according to the manufacturer's instruction. Nucleotide sequences were determined by direct sequencing using Big-Dye terminator cycle sequencing kit and an ABI Prism 310 Genetic Analyzer (Applied Biosystems, Foster City, CA). Norovirus genotypes were initially determined by Blast Tool (National Center for Biotechnology Information) and Norovirus Typing Tool [19] and confirmed by phylogenetic analysis of the nucleotide sequences of partial VP1 gene.
Determination of norovirus viral load by multiplex
real-time RT-PCR Viral load was quantified by multiplex real-time RT-PCR [18, 20, 21] using an ABI 7500 FAST real-time PCR system (Applied Biosystems) with SensiFAST Probe Lo-ROX Master Mix (Bioline Reagents Ltd, London, UK). Primers and probes used are listed in Table 1 . Negative control wells (H 2 O) and GI and GII norovirus standard plasmids (Invitrogen, Carlsbad, CA, USA) were included in each run. At the end of the run, baseline (threshold Ct) values were adjusted manually. Quantitation of GI and GII noroviruses was achieved based on standard curves generated from standard plasmids. Standard curves were established by using a 10-fold serial dilution of GI and GII norovirus plasmids ranging from 1 Â 10 1 -1 Â 10 7 copies/ml. Samples with a Ct value higher than those of negative control wells were considered negative.
Evaluation of sensitivity, specificity and crossreactivity of the tests Specificity of IC assay was evaluated by using both norovirus-positive (n ¼ 32) and -negative (n ¼ 8) fecal specimens. The percentage of specificity was calculated by the following formula: number of specimen that are positive or negative by IC kit number of specimen that are positive or negative by RT À PCR or real À time RT À PCR Â 100
Evaluation of cross-reactivity of IC kit was considered for a group of seven fecal specimens that were negative for norovirus but positive for group A rotavirus, adenovirus, astrovirus or sapovirus. Ideally, norovirus-negative samples should also be negative when tested with the IC assay, indicating no cross-reactivity. 
R E S U L T S
Detection of norovirus by IC assay, RT-PCR and real-time RT-PCR From 40 fecal specimens, as tested by RT-PCR, 32 were norovirus-positive and 8 were norovirus-negative samples (Table 2 ). Among 32 norovirus-positive specimens, five were co-infected with group A rotavirus, enterovirus, saffold virus or adenovirus. Among eight norovirus-negative specimens, seven were positive for group A rotavirus, adenovirus, astrovirus or sapovirus, and one was negative for both norovirus and other gastroenteritis viruses. Norovirus identification by BLAST tool and phylogenetic analysis of 32 norovirus-positive specimens revealed a wide variety of norovirus genotypes including 22 of GII.4, two each of GII.7 and GII.17, and one each of GI.5, GII.3, GII.6, GII.14, GII.15 and GII.21. All specimens that were positive and negative for norovirus detection by IC kit were also positive and negative for norovirus by RT-PCR and real-time RT-PCR. Viral load in fecal specimens as detected by real-time RT-PCR ranged from 6.2 Â 10 4 -1.1 Â 10 11 copies/g of stool.
Comparison of sensitivity To assess sensitivity of IC detection assay, 32 norovirus-positive specimens were tested by the IC kit in comparison with RT-PCR and real-time RT-PCR. As shown in Tables 2 and 3 , all 32 specimens were positive for norovirus as detected by IC kit and PCR-based methods, demonstrating the 100% sensitivity for the IC assay ( Table 3 ). The IC kit successfully detected GI.5 norovirus and broad range of GII norovirus genotypes including GII.3, GII.4, GII.6, GII.7, GII.14, GII.15, GII.21 and recent emerging GII.17. All GII.4 noroviruses, the most predominant genotype in this study (68.8%, 22 of32), were positive by this IC kit. However, GI.5, GII.6 and GII.17 genotypes showed weak positive by this kit. The data indicated that the sensitivity of norovirus detection by IC kit was comparable with those of RT-PCR and real-time RT-PCR.
Determination of specificity and cross-reactivity Specificity of IC assay was evaluated in comparison with those of gold standard methods. The true norovirus-positive (n ¼ 32; GI ¼ 1 and GII ¼ 31) andnegative (n ¼ 8) fecal specimens as tested by RT-PCR and real-time RT-PCR must be positive or negative, respectively, by IC kit. The results showed that all 32 norovirus-positive specimens and 8 norovirus-negative specimens as tested by RT-PCR and real-time RT-PCR were also positive and negative, respectively, by IC kit (Tables 2 and 3 ). The data indicated that the specificity of IC kit was 100%.
To evaluate the IC kit for cross-reactivity, a group of seven fecal specimens that were negative for norovirus but positive for group A rotavirus, adenovirus, astrovirus or sapovirus were tested. The results showed that all these specimens were negative for norovirus by IC assay, RT-PCR and real-time PCR. These data indicated that no cross-reactivity was observed as tested by all three methods and all in 100% agreement.
D I S C U S S I O N
Noroviruses are a major cause of gastroenteritis worldwide and frequently involved in outbreaks in common facilities, such as hospital, school and on [2, 5, 6] . Still, the usefulness of PCR-based methods in clinical settings is limited because of they are time-consuming, expensive as well as require expensive laboratory equipment. Advantages of the IC assay are cost effectiveness, speed and ease of use at the bedside without the requirement of special equipment. To date, several rapid IC kits for norovirus detection are commercially available. Among them, the RIDA V R QUICK Norovirus IC assay for detection of norovirus in stool samples has been evaluated in many studies with good sensitivity (52-87%) and specificity (98-100%) compared with other IC kits [7, 11, 12, [22] [23] [24] .
According to the manufacturer description, the reactivity of IC assay is based on monoclonal antibodies that are reactive to the antigens of both GI and GII of norovirus in fecal samples. In this study, a latest version of RIDA V R QUICK Norovirus kit was tested with fecal specimens from pediatric patients with acute gastroenteritis and compared with PCRbased methods. This study demonstrated a high sensitivity and specificity of the IC kit for norovirus detection, which is comparable with RT-PCR and realtime RT-PCR. The specificity (100%) of the IC kit as seen in this study is in good agreement with those of other reports (97-100%) [7, 8, 11, 12, 25] . However, the sensitivity of the IC assay reported in this study is higher than those of other studies (52-83%) as summarized in Table 4 [7, 8, 12, 23, 25] . The differences in the sensitivity of the IC kit between this study and other studies might be explained by the difference in the genotypes of norovirus in the fecal specimens tested, the gold standard PCR method used and the difference in version of the IC kit. It should be noted that this study and Bruggink's study [11] used the updated version of the RIDA V R QUICK Norovirus IC kit (Version N1402), while other studies tested with previous version. By using the latest version, broader genotypes of GI and GII noroviruses could be successfully detected such as GI.2, GI4, GII.6 and GII.7. These genotypes of norovirus could not be detected by the previous version of IC kit [7] . Moreover, when analyzed carefully, it was found that the sensitivity of IC test with specific genotype of norovirus, especially GII.4, which is the most prevalent genotype worldwide [2, 26, 27] , observed between this study (100%, 22 of 22) and that from Bruggink's study was similar (98%, 54 of 55) [11] . Altogether, the sensitivity of IC assay is often dependent on the genotype of norovirus, brand and version of the IC kit. This study found that GI.5, GII.6 and GII.17 noroviruses were weak positive by IC test. The low reactivity of this IC kit with GI and GII.6 was described previously [7, 12, 25] . For the novel GII.17 norovirus, this study barely detected the two GII.17 noroviruses that had different levels of viral load (CMHST14/14 and CMHS200/15 with 6.2 Â 10 4 and 5.0 Â 10 7 copies/g of stool, respectively). Although the viral load is clearly essential for the ability and reactivity of IC assay, other factors may influence the test's performance. In fact, these two samples were collected from different area in Chiang Mai province, and thus, the viruses may potentially have antigenic difference. In addition, because the novel GII.17 has been emerged recently in Asia in 2014-15 [28] [29] [30] [31] [32] , perhaps this IC kit might not be highly efficient for the detection of new strain of norovirus.
In conclusion, this study demonstrated that the updated version of RIDA V R QUICK Norovirus IC assay (N1402) could detect various genotypes of norovirus without cross-reactivity with other common diarrheal viruses and had high sensitivity and specificity. It could be an alternative choice for rapid screening or a quick diagnostic tool for norovirus detection in fecal specimens, especially during the season of acute gastroenteritis outbreak. 
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